HISTOGENICS CORP COMMON (HSGX) earnings
Quarterly and annual HSGX reports and results, each read against the price at its own news timestamp. Back to the HSGX overview →
No HSGX earnings events in the measured window.
Nothing matched in the current window — the HSGX overview has every event we measure for this name.
Get an email when HSGX moves on news →Keep exploring
More HSGX: analyst actions → · SEC filings → · HSGX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PhaseBio Pharmaceuticals, Inc. (PHAS) | 385 | 0.00% | 48% |
| ARADIGM CORP COMMON STOCK (ARDM) | 384 | 0.00% | 39% |
| Amicus Therapeutics, Inc. (FOLD) | 382 | +0.04% | 51% |
| CORIUM INTL (CORI) | 380 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.